C. Li et al., PROTEIN N-ARGININE METHYLATION IN ADENOSINE DIALDEHYDE-TREATED LYMPHOBLASTOID-CELLS, Archives of biochemistry and biophysics, 351(1), 1998, pp. 53-59
Protein arginine methyltransferase was recently identified to be assoc
iated with some proteins in signal transduction pathways. N-Arginine m
ethylation in RNA binding proteins with arginine-and glycine-rich RGG
motifs is known to be the major protein methylation in cells. Consider
ing that arginine methylation might be involved in certain human disor
ders, we used human lymphoblastoid cells that can be easily prepared f
rom lymphocytes as a model system to study the methylation. Lymphoblas
toid cells grown in the presence of 20 mu M indirect methyltransferase
inhibitor adenosine dialdehyde (AdOx) for 72 h appeared to accumulate
high levels of hypomethylated proteins for the endogenous protein met
hyltransferase or recombinant glutathion S-transferase-fused yeast arg
inine methyltransferase (RMT1). Analysis of methyl-accepting polypepti
des in AdOx-treated lymphoblastoid cells by SDS-PAGE and fluorography
showed that many polypeptides between 29,000 and 90,000 Pa were methyl
ated by the endogenous methyltransferase. A few polypeptides could be
methylated to a higher extent upon the addition of yeast GST-RMT1 fusi
on protein. A peptide (GGRGRGGGF) could compete for the majority of th
e methyl-accepting protein substrates in the AdOx-treated lymphoblasto
id cell extracts, whether or not exogenous yeast RMT1 was included in
the reaction, When the arginine residues in the peptide were replaced
by lysine, no competition was observed. The results indicated that the
protein methyl accepters in lymphoblastoid cells share similar RGG mo
tifs and that arginine residues should be the site of methylation. (C)
1998 Academic Press.